Ionis Pharmaceuticals, Inc.
IONS
$81.84
$0.530.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.24B | 2.29B | 2.15B | 2.30B | 2.49B |
| Total Receivables | 24.61M | 52.58M | 39.71M | 92.19M | 17.93M |
| Inventory | 10.47M | 8.48M | 11.50M | 12.51M | 28.45M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 240.49M | 223.12M | 219.49M | 212.67M | 176.50M |
| Total Current Assets | 2.52B | 2.58B | 2.42B | 2.62B | 2.71B |
|
|
|||||
| Total Current Assets | 2.52B | 2.58B | 2.42B | 2.62B | 2.71B |
| Net Property, Plant & Equipment | 348.11M | 275.88M | 262.19M | 256.11M | 246.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 113.78M | 109.28M | 90.80M | 86.26M | 79.30M |
| Total Assets | 3.03B | 2.99B | 2.81B | 3.00B | 3.08B |
|
|
|||||
| Total Accounts Payable | 14.33M | 22.80M | 17.46M | 42.96M | 9.05M |
| Total Accrued Expenses | 156.33M | 145.52M | 129.31M | 178.05M | 164.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 655.71M | 652.92M | 22.30M | 9.28M | 54.50M |
| Total Finance Division Other Current Liabilities | 77.09M | 75.99M | 81.22M | 79.02M | 76.06M |
| Total Other Current Liabilities | 77.09M | 75.99M | 81.22M | 79.02M | 76.06M |
| Total Current Liabilities | 903.46M | 897.24M | 250.29M | 309.32M | 304.57M |
|
|
|||||
| Total Current Liabilities | 903.46M | 897.24M | 250.29M | 309.32M | 304.57M |
| Long-Term Debt | 1.14B | 1.17B | 1.79B | 1.79B | 1.77B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 262.67M | 164.38M | 159.39M | 161.81M | 168.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 107.91M | 125.10M | 140.68M | 156.50M | 173.78M |
| Total Liabilities | 2.42B | 2.35B | 2.34B | 2.42B | 2.42B |
|
|
|||||
| Common Stock & APIC | 3.05B | 2.93B | 2.90B | 2.87B | 2.83B |
| Retained Earnings | -2.40B | -2.27B | -2.40B | -2.25B | -2.15B |
| Treasury Stock & Other | -25.98M | -27.99M | -28.95M | -30.81M | -24.17M |
| Total Common Equity | 617.97M | 631.72M | 475.73M | 588.35M | 662.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 617.97M | 631.72M | 475.73M | 588.35M | 662.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 617.97M | 631.72M | 475.73M | 588.35M | 662.47M |
|
|
|||||